Marker Therapeutics, Inc. (MRKR) Form 10-Q Quarterly Reports
Marker Therapeutics, Inc. (MRKR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MRKR
CIK: 1094038
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMatthew Taylor
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001104659-26-097262 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001104659-26-062763 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-05-01 | FORM 8-K | 0001104659-26-054940 | View SEC Doc Filr Page |
| DEFA14A | 2026-03-20 | — | DEFA14A | 0001104659-26-032708 | View SEC Doc Filr Page |
| ARS | 2026-03-20 | 2025-12-31 | ARS | 0001104659-26-032704 | View SEC Doc Filr Page |
| DEF 14A | 2026-03-20 | 2026-05-01 | FORM DEF 14A | 0001104659-26-032694 | View SEC Doc Filr Page |
| 8-K | 2026-03-19 | 2026-03-18 | FORM 8-K | 0001104659-26-031309 | View SEC Doc Filr Page |
| 10-K | 2026-03-18 | 2025-12-31 | 10-K | 0001104659-26-031274 | View SEC Doc Filr Page |
| PRE 14A | 2026-03-10 | 2026-05-01 | FORM PRE 14A | 0001104659-26-025917 | View SEC Doc Filr Page |
| 8-K | 2026-02-09 | 2026-02-09 | FORM 8-K | 0001104659-26-012063 | View SEC Doc Filr Page |
| 4 | 2025-11-19 | 2025-11-17 | PRIMARY DOCUMENT | 0001768011-25-000003 | View SEC Doc Filr Page |
| 4 | 2025-11-19 | 2025-11-17 | PRIMARY DOCUMENT | 0001270905-25-000003 | View SEC Doc Filr Page |
| 4 | 2025-11-19 | 2025-11-17 | OWNERSHIP DOCUMENT | 0001104659-25-114081 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-11-17 | — | SCHEDULE 13D/A Filing | 0001072613-25-000858 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-11-14 | — | SCHEDULE 13G/A Filing | 0001172661-25-005191 | View SEC Doc Filr Page |
| 8-K | 2025-11-14 | 2025-11-14 | FORM 8-K | 0001104659-25-111940 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | 10-Q | 0001104659-25-111502 | View SEC Doc Filr Page |
| 8-K | 2025-11-05 | 2025-10-31 | FORM 8-K | 0001104659-25-106669 | View SEC Doc Filr Page |
| 4 | 2025-11-04 | 2025-10-31 | PRIMARY DOCUMENT | 0001884123-25-000010 | View SEC Doc Filr Page |
| 4 | 2025-11-04 | 2025-10-31 | PRIMARY DOCUMENT | 0001755495-25-000003 | View SEC Doc Filr Page |
| 3 | 2025-11-04 | 2025-10-31 | PRIMARY DOCUMENT | 0001884123-25-000009 | View SEC Doc Filr Page |
| 8-K | 2025-10-06 | 2025-10-06 | FORM 8-K | 0001104659-25-096935 | View SEC Doc Filr Page |
| 8-K | 2025-08-26 | 2025-08-26 | FORM 8-K | 0001104659-25-082783 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-08-20 | — | SCHEDULE 13D/A Filing | 0001104659-25-080957 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-08-19 | — | SCHEDULE 13D/A Filing | 0001104659-25-080213 | View SEC Doc Filr Page |